Atabak Mokari

Companies

• Corcept TherapeuticsChief financial officer Mar 3, 2021 to now¹
• BELLICUM PHARMACEUTICALS, INCChief financial officer Dec 20, 2018 to Apr 9, 2020²
• IRIDEX CORPChief financial officer Jul 13, 2016 to Dec 13, 2018³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Corcept Therapeutics CORT16,304 shares⁴$1.8M at $112.37Sep 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 2, 2026Shares withheld for tax 102 shares at $113.38 of Corcept Therapeutics⁴
• Sep 1, 2026Granted 138 shares of Corcept Therapeutics⁴
• Sep 1, 2026Granted 138 shares at $113.38 of Corcept Therapeutics⁴
• Jul 30, 2026Sold 1,001 shares at $120.67 of Corcept Therapeutics⁵
• Jul 30, 2026Sold 8,103 shares at $119.95 of Corcept Therapeutics⁵
• Jul 30, 2026Sold 4,783 shares at $118.73 of Corcept Therapeutics⁵
• Jul 30, 2026Sold 8,267 shares at $117.93 of Corcept Therapeutics⁵
• Jul 30, 2026Sold 7,089 shares at $116.96 of Corcept Therapeutics⁵
• Jul 30, 2026Sold 14,222 shares at $115.87 of Corcept Therapeutics⁵
• Jul 30, 2026Sold 15,477 shares at $114.96 of Corcept Therapeutics⁵
• Jul 30, 2026Sold 4,700 shares at $113.18 of Corcept Therapeutics⁵
• Jul 30, 2026Sold 600 shares at $110.95 of Corcept Therapeutics⁵
• Jul 30, 2026Sold 2,202 shares at $110.03 of Corcept Therapeutics⁵
• Jul 30, 2026Sold 400 shares at $108.46 of Corcept Therapeutics⁵
• Jul 30, 2026Sold 8,956 shares at $106.96 of Corcept Therapeutics⁵
• Jul 30, 2026Sold 4,200 shares at $105.54 of Corcept Therapeutics⁵
• Jul 30, 2026Exercised options 80,000 shares at $23.06 of Corcept Therapeutics⁵
• Jul 15, 2026Sold 101 shares at $89.43 of Corcept Therapeutics⁶
• Jul 15, 2026Sold 3,520 shares at $88.30 of Corcept Therapeutics⁶
• Jul 15, 2026Sold 28,460 shares at $87.89 of Corcept Therapeutics⁶
• Jul 15, 2026Sold 7,919 shares at $86.78 of Corcept Therapeutics⁶
• Jul 15, 2026Exercised options 24,167 shares at $23.06 of Corcept Therapeutics⁶
• Jul 15, 2026Exercised options 15,833 shares at $19.26 of Corcept Therapeutics⁶
• Jun 15, 2026Sold 2 shares at $82.45 of Corcept Therapeutics⁷
• Jun 15, 2026Sold 19,483 shares at $81.81 of Corcept Therapeutics⁷